ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1344

The Positive Synovial Fluid Culture:  Septic Arthritis or Contamination?

Clara Zhu1, Mary Louise Fowler2, Sarah B. Lieber3, Andrew Moore4, Robert H. Shmerling5 and Ziv Paz3, 1Medical School, Boston University School of Medicine, Boston, MA, 2School of Medicine, Boston University School of Medicine, Boston, MA, 3Beth Israel Deaconess Medical Center, Boston, MA, 4Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, 5Medicine, Beth Israel Deaconess Medical Center, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Arthritis and infection

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Infection-related Rheumatic Disease: Poster Session

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Isolation of bacteria from synovial fluid (SF) is the gold standard for the diagnosis of septic arthritis (SA). However, false positive culture results (contamination) can result in misdiagnosis and mismanagement.  Little is known about the microbiologic profile of contaminated SF (cSF) cultures, the clinical presentation of such cases, outcomes and rates of alternative diagnoses.  The purpose of this study is to characterize the demographic features, clinical characteristics, microbiology and outcomes of patients diagnosed withcSF and to compare them with patients with SA

Methods: We conducted a retrospective study including all patients ages 18 and older admitted to a single, tertiary-case hospital between 1998 and 2015 with suspected SA with positive SF cultures.  The diagnosis of cSF was determined by infectious disease specialists involved in the patients’ care. 

Results: 371 patients with SA and 25 patients with cSF were identified. The groups were significantly different with regard to age (58.9 vs. 68.2; p<0.01). The most frequently involved joint was the knee but ankle involvement was relatively more common among those with cSF (Figure 1). The clinical presentations were different between the groups: 35.3% of the patients with SA and 16% of those with cSF presented with fever (p<0.01); ESR and CRP were significantly higher in the SA group (76.1 (mm/hr) vs. 52.3 (mm/hr) and 145.3 (mg/L) vs. 64.4 (mg/L) respectively; p<0.01 for each comparison).  Similarly, the mean SF white blood cell count (in thousands) was higher in the SA group (89.2 vs. 36.7; p< 0.01). The mean number of days until the first positive culture results in the group with cSF was 3.2 days.  The most common organism identified in the cSF group was coagulase-negative staphylococcus [Figure 2]. The mean length of stay (11 vs. 6.2), ICU admission rates (15.9% vs. 4%) and rates of alternative diagnoses (1.3% vs. 36%) within one year were significantly different (p<0.01 for all comparisons) between patients in the SA and cSF groups. 

Conclusion: This study suggests that cSF is identified in up to 6% of patients with suspected SA and positive SF cultures . These patients present with less severe disease, better outcomes and an alternative diagnosis in 36% of the cases within one year. The unique characteristics of this group include their less severe presentation and delayed and minimal growth of organisms with low pathogenicity.  Based on this study, we recommend a conservative approach for patient with suspected SA with mild disease manifestations and no growth of pathogenic organisms within the first 48 hours.


Disclosure: C. Zhu, None; M. L. Fowler, None; S. B. Lieber, None; A. Moore, None; R. H. Shmerling, None; Z. Paz, None.

To cite this abstract in AMA style:

Zhu C, Fowler ML, Lieber SB, Moore A, Shmerling RH, Paz Z. The Positive Synovial Fluid Culture:  Septic Arthritis or Contamination? [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-positive-synovial-fluid-culture-septic-arthritis-or-contamination/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-positive-synovial-fluid-culture-septic-arthritis-or-contamination/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology